Gehost op MSN19d
Another win for Clarity at FDA as imaging agent fast-tracked for complex prostate cancer
For those unlucky enough to have received a testicular castration to treat prostate cancer, only for it to come back, Clarity Pharmaceuticals’ (ASX:CU6) news on Wednesday morning could offer ...